1001 CAT-248 (engineered NK cells expressing CD70 CAR, IL15, and TGFβ DNR) demonstrates in vivo expansion, tumor infiltration, and durable regression of multiple CD70-expressing xenograft tumors

1001 CAT-248 (engineered NK cells expressing CD70 CAR, IL15, and TGFβ DNR) demonstrates in vivo expansion, tumor infiltration, and durable regression of multiple CD70-expressing xenograft tumors

Bibliographic Details
Main Authors: Branden Moriarity, Marilyn Marques, Vipin Suri, Bashar Hamza, Angela Nunez, Henry Moreno, Alexia Barandiaran, Evelyn Warren, Cristina Panaroni, Michele McAuliffe, Krista Daniel, Julianne Murthy, Keith HK Wong, Mark Omobono, Priya Khurana, Beatriz Marques, Adriana Rivera, Jae Woong Chang, Joseph Gold, Cherry Thomas, Dominic Picarella
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items